Dr. Andreas Schmidt is a Co-Founder of AYOXXA Biosystems GmbH. While leading AYOXXA as CEO until October 2016, the company developed its core technology and expanded to about 35 employees operating from three sites in Cologne, Singapore and Boston. Andreas Schmidt obtained a PhD in molecular and cell biology jointly from the University of Cologne and the University of California, Berkeley and he received several prestigious fellowships and awards in the USA, Germany, China, Taiwan and Singapore. Dr. Schmidt served on the advisory board of the German Academic International Network (GAIN) for North America and is a board member, advisor and mentor for several biotech companies.

Prof. Dr. Dieter Trau is a Co-Founder of AYOXXA Biosystems GmbH and the inventor of AYOXXA’s proprietary bead-based platform technology. Prof. Trau has more than 25 years of experience in bioanalytics. Prof. Trau is Associate Professor at the Department of Biomedical Engineering and the Department of Chemical & Biomolecular Engineering at the National University of Singapore (NUS). Prof. Trau served as Assistant Professor at the Department of Biomedical Engineering and the Department of Chemical & Biomolecular Engineering at the National University of Singapore since 2004. Prof. Trau holds an engineering degree from the Jülich/Aachen University of Applied Sciences in Germany and a PhD in chemistry from the Hong Kong University of Science and Technology (HKUST).